All News GeoVax Labs, Inc.

Equities

GOVX

US3736786068

Delayed Nasdaq Other stock markets 12:35:10 2024-05-06 pm EDT			5-day change	1st Jan Change
1.7 ^USD	+5.59%		+14.58%	-69.53%

Mar. 28	GeoVax Labs, Inc. to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress	CI
Mar. 06	GeoVax Labs, Inc. Achieves Milestone in Transition to Commercially Validated Manufacturing System	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine	Apr. 04	AQ
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress	Mar. 28	AQ
GeoVax Labs, Inc. to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress	Mar. 28	CI
GeoVax to Present at the 36th Annual Roth Conference	Mar. 12	AQ
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System	Mar. 06	AQ
GeoVax Labs, Inc. Achieves Milestone in Transition to Commercially Validated Manufacturing System	Mar. 06	CI
Transcript : GeoVax Labs, Inc., Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update	Feb. 29	AQ
GeoVax Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024	Feb. 22	AQ
GeoVax to Present at the 2024 BIO CEO & Investor Conference	Feb. 19	AQ
GeoVax Labs Gets Two Patents from US Patent and Trademark Office	Feb. 13	MT
GeoVax Announces Multiple Patent Issuances and Allowances	Feb. 13	AQ
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster	Feb. 06	AQ
Geovax Reports Positive Interim Data from Phase 2 Clinical Trial of Geo-Cm04s1 as A Universal Covid-19 Vaccine Booster	Feb. 06	CI
Reverse Split: 1 of 15	Jan. 30	FA
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement	Jan. 29	AQ
Transcript : GeoVax Labs, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 02:30 PM	Jan. 08
GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology	Jan. 08	AQ
Geovax Appoints Marc Pipas as Executive Medical Director, Oncology	Jan. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News GeoVax Labs, Inc.

Equities

GOVX

US3736786068

All News

Filters